MyChesCo on MSN5d
Ocugen Secures EMA Orphan Designation for OCU410ST, Advancing Stargardt Disease Treatment
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received orphan medicinal product designation from the European Medicines ...
Ocugen announces EMA granted orphan medicinal product designation for OCU410ST
Ocugen (OCGN) announced that the European Medicines Agency, EMA, has granted orphan medicinal product designation for OCU410ST for the ...
Medscape25d
The Genetics of Hereditary Retinopathies and Optic Neuropathies
For mere clinical classification purposes, rod-cone dystrophies can be broadly divided into early onset forms (i.e., which are either consistently severe from birth with little progression ...
eLife4d
Single cell transcriptomics reveals early photoreceptor states, cell-specific transcript isoforms, and cancer-predisposing features
Here, we used deep full-length single-cell RNA-sequencing to distinguish post-mitotic cone and rod developmental states and cone-specific features that contribute to retinoblastomagenesis. The ...
Ocugen Receives Orphan Medicinal Product Designation From EMA For OCU410ST
Ocugen, Inc. (OCGN) announced the European Medicines Agency has granted orphan medicinal product designation for OCU410ST for the ...